VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021LA Controversies: Need for Oral Lead-In and How to Cover Tail of Injectable LA RegimensView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Special Populations Including End Organ Failure: Focus on Long-Acting Cabotegravir and RilpivirineView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021DDIsView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Pharmacological Considerations for Special PopulationsView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Immune Checkpoint Inhibitors in the Treatment of HBVView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Pharmacologically Focused to Optimize HIV Prevention for Transgender WomenView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Charles Boucher Memorial LectureView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Small Molecules and mAbs as Antiviral Therapy for COVID-19View Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIVView Video
Scientific ReportHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Meeting Report Day 3 | V. Bukkems | by M. MascoliniView Scientific Report
Scientific ReportHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Meeting Report Day 2 | J. Castillo-Mancilla | by M. MascoliniView Scientific Report
Scientific ReportHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021Meeting Report Day 1 | N. Thakkar | | by M. MascoliniView Scientific Report
